Financial Daily from THE HINDU group of publications
Friday, Apr 23, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Marketing - New Products & Services


Maxfair's ayurvedic drugs

Our Bureau

KOCHI: The Nashik-based Maxfair Drugs and Cosmetics Pvt Ltd has launched its various ayurvedic products in the Kerala market. The products included medicines for respiratory disorder, joint pain, piles, hypertension etc.

Speaking on the occasion, Mr Ranjan Mohapatra, Managing Director said that the initial launch of the products was in Nagpur in August last year and there was an overwhelming response from various parts in the country.

The company is confident of achieving its targeted sales turnover of Rs 20 crore during the fiscal 2004-05, he said.

In Kerala, the company is planning to organise road shows and medical camps in the rural and urban centres for the promotion of the product.

The company has already put pan-India distribution network in place to reach the deeper pockets from its factory at Champa in Chhattisgarh.

More products for acidity, allergic cough and cold, cardio care and obesity would be introduced by next month, he added.

More Stories on : New Products & Services | Alternative Medicines | Kerala

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Splash to spruce up content


Switch on your AC with a phone call!
Alleged misleading advertisement — MRTPC rejects Nirma's plea against HLL
Singapore Tourism to come out with special packages
Total targets 25 pc growth in lubricants
Raymond promises `divine' feel with 220S
Vanilla Coke in Chennai
Kodak launches new dry tech laser radiology machine
Maxfair's ayurvedic drugs



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line